Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (251-260 of 259) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 259 results.
Aging Clinical and Experimental Research|July 21, 2022
Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approachNicholas Fuggle, Nathalie Bere, Olivier Bruyère, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction ModelingMehreen Soomro, Michael Stadler, Nick Dand, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.
Annals of the Rheumatic Diseases|March 6, 2012
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisDanielle M Gerlag, Karim Raza, Lisa G M van Baarsen, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Pageof 26

Showing results (251-260 of 259) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
Aging Clinical and Experimental Research|July 21, 2022
Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approachNicholas Fuggle, Nathalie Bere, Olivier Bruyère, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 4, 2022
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction ModelingMehreen Soomro, Michael Stadler, Nick Dand, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.
Annals of the Rheumatic Diseases|March 6, 2012
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisDanielle M Gerlag, Karim Raza, Lisa G M van Baarsen, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.
Annals of the Rheumatic Diseases|August 11, 2022
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an updateDaniel Aletaha, Andreas Kerschbaumer, Kastriot Kastrati, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
Autoimmunity Reviews|April 25, 2017
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosusJean-François Kleinmann, Florence Tubach, Véronique Le Guern, et al.
Pageof 26